Pathology of Early Hepatocellular Carcinoma: Conventional and Molecular Diagnosis

被引:106
|
作者
Roskams, Tania [1 ]
Kojiro, Masamichi [2 ]
机构
[1] Univ Louvain, Dept Morphol & Mol Pathol, B-3000 Louvain, Belgium
[2] Kurume Univ, Kurume, Fukuoka 830, Japan
关键词
Hepatocellular carcinoma; stromal invasion; dysplastic nodule; glypican-3; heat shock protein 70; glutamine synthetase; nodule-in-nodule; AMMONIA-METABOLIZING ENZYMES; CIRRHOTIC LIVER EXPLANTS; GRADE DYSPLASTIC NODULES; HUMAN HEPATOCARCINOGENESIS; GLUTAMINE-SYNTHETASE; MACROREGENERATIVE NODULES; GLYPICAN-3; EXPRESSION; PRENEOPLASTIC LESIONS; MARKER; CELLS;
D O I
10.1055/s-0030-1247129
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recently, an East-West consensus on the histopathologic criteria for the diagnosis of high-grade dysplastic nodules (HGDN) versus early hepatocellular carcinoma (HCC) was reached. Next to classical morphologic criteria such as nucleocytoplasmic ratio, thickness of cell plates, mitotic index, and architectural disturbance like acinar structures, one of the most relevant criteria to diagnose early HCC is stromal invasion. Because a structured basement membrane is lacking along the hepatocytes in the liver, invasion cannot be defined as tumor growth through the basement membrane as in other tissues. However, the number of portal tracts that are present in a nodule gradually decrease because the tumoral hepatocytes start to show a destructive invading growth pattern in the mesenchyma/stroma of these portal tracts. This feature of stromal invasion is however sometimes difficult to recognize in needle biopsies because included portal tracts can be absent. Therefore, other diagnostic criteria are necessary. Based on molecular profiling, several additional markers for early malignant HCC have been found recently. Glypican-3, heat shock protein 70, and glutamine synthetase have been already validated and can be used as a panel of stains to confirm the pathologist's histopathologic diagnosis and to solve difficult cases.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
  • [31] Hepatocellular Carcinoma: Molecular Diagnosis and Perspectives for Therapy
    Premkumar, Madhumita
    Chawla, Yogesh
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (06)
  • [32] Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma
    Varma, V
    Cohen, C
    ADVANCES IN ANATOMIC PATHOLOGY, 2004, 11 (05) : 239 - 249
  • [33] Serum profile of low molecular weight fucosylated glycoproteins for early diagnosis of hepatocellular carcinoma
    Yao, Weirong
    Wang, Kaiyu
    Jiang, Yu
    Huang, Zhufeng
    Huang, Yiyun
    Yan, Huihui
    Huang, Suhong
    Chen, Min
    Liao, Jian
    ONCOLOGY LETTERS, 2020, 20 (02) : 1597 - 1606
  • [34] Conventional and molecular techniques for the early diagnosis of bacteraemia
    Paolucci, Michela
    Landini, Maria Paola
    Sambri, Vittorio
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 : S6 - S16
  • [35] Pathology of hepatocellular carcinoma
    Longerich, Thomas
    Schirmacher, Peter
    PATHOLOGIE, 2022, 43 (01): : 67 - 75
  • [36] Pathology of hepatocellular carcinoma
    Longerich, Thomas
    Schirmacher, Peter
    PATHOLOGE, 2022, 43 (01): : 67 - 78
  • [37] Pathology of hepatocellular carcinoma
    Pfeifer, U
    DIGESTION, 1998, 59 : 66 - 69
  • [38] Pathology of hepatocellular carcinoma
    Tannapfel, A
    Wittekind, C
    CHIRURGISCHE GASTROENTEROLOGIE, 2003, 19 (03): : 225 - 230
  • [39] Unexpected Diagnosis of Cirrhotomimetic Hepatocellular Carcinoma on Explant Pathology: A Case Report
    Cornejo, Jose Barandiaran
    Selvaggi, Gennaro
    Ruiz, Felipe
    Vianna, Rodrigo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S36 - S36
  • [40] Pathology quiz case: Diagnosis: Mandibular metastasis of hepatocellular carcinoma (HCC)
    Chen, SY
    Cheng, PW
    Tsai, CC
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (08) : 735 - 736